Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Diffusion-Weighted Magnetic Resonance Imaging to Detect Synchronous Uterine Endometrial and Endocervical Adenocarcinoma

Diffusion-Weighted Magnetic Resonance Imaging to Detect Synchronous Uterine Endometrial and... Abstract Synchronous endometrial and cervical cancer is a very rare condition. This report describes a case of a 46-year-old woman who presented with a cervical mass that measured 5.6 cm along its longest diameter, whose biopsy analysis revealed an endocervical mucinous adenocarcinoma. She was classified as having an IB2 cervical carcinoma and treated with concurrent chemoradiation plus hysterectomy. Pathological and immunohistochemical analysis of the surgical specimens revealed a synchronous endometrioid grade 2 adenocarcinoma in the endometrium, and a well-differentiated mucinous adenocarcinoma in the cervix. Magnetic resonance imaging (MRI) studies performed prior to treatment were reviewed and apparent diffusion coefficient (ADC) maps were generated. The ADC values demonstrated distinct signal intensity differences between the endometrial and endocervical tumors. In conclusion, diffusion-weighted MRI and ADC maps can help to distinguish the site of origin of synchronous tumors. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Rare Tumors SAGE

Diffusion-Weighted Magnetic Resonance Imaging to Detect Synchronous Uterine Endometrial and Endocervical Adenocarcinoma

Diffusion-Weighted Magnetic Resonance Imaging to Detect Synchronous Uterine Endometrial and Endocervical Adenocarcinoma

Rare Tumors , Volume OnlineFirst: 1 – Mar 1, 2012

Abstract

Abstract Synchronous endometrial and cervical cancer is a very rare condition. This report describes a case of a 46-year-old woman who presented with a cervical mass that measured 5.6 cm along its longest diameter, whose biopsy analysis revealed an endocervical mucinous adenocarcinoma. She was classified as having an IB2 cervical carcinoma and treated with concurrent chemoradiation plus hysterectomy. Pathological and immunohistochemical analysis of the surgical specimens revealed a synchronous endometrioid grade 2 adenocarcinoma in the endometrium, and a well-differentiated mucinous adenocarcinoma in the cervix. Magnetic resonance imaging (MRI) studies performed prior to treatment were reviewed and apparent diffusion coefficient (ADC) maps were generated. The ADC values demonstrated distinct signal intensity differences between the endometrial and endocervical tumors. In conclusion, diffusion-weighted MRI and ADC maps can help to distinguish the site of origin of synchronous tumors.

Loading next page...
 
/lp/sage/diffusion-weighted-magnetic-resonance-imaging-to-detect-synchronous-OKc8j7zolC

References (16)

Publisher
SAGE
Copyright
© 2012 SAGE Publications.
ISSN
2036-3613
eISSN
2036-3613
DOI
10.4081/rt.2012.e19
Publisher site
See Article on Publisher Site

Abstract

Abstract Synchronous endometrial and cervical cancer is a very rare condition. This report describes a case of a 46-year-old woman who presented with a cervical mass that measured 5.6 cm along its longest diameter, whose biopsy analysis revealed an endocervical mucinous adenocarcinoma. She was classified as having an IB2 cervical carcinoma and treated with concurrent chemoradiation plus hysterectomy. Pathological and immunohistochemical analysis of the surgical specimens revealed a synchronous endometrioid grade 2 adenocarcinoma in the endometrium, and a well-differentiated mucinous adenocarcinoma in the cervix. Magnetic resonance imaging (MRI) studies performed prior to treatment were reviewed and apparent diffusion coefficient (ADC) maps were generated. The ADC values demonstrated distinct signal intensity differences between the endometrial and endocervical tumors. In conclusion, diffusion-weighted MRI and ADC maps can help to distinguish the site of origin of synchronous tumors.

Journal

Rare TumorsSAGE

Published: Mar 1, 2012

Keywords: endometrial cancer; cervical cancer; synchronous tumors; magnetic resonance imaging; functional; neoplasm; multiple primary

There are no references for this article.